analyst
TA
NASDAQ · TARS
Tarsus Pharmaceuticals, Inc. Common Stock
Healthcare · Biotechnology
$78.09
Down-$0.94 (-1.19%)
Updated Sep 19, 2026, 1:01 PM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.47B
- P/E ratio
- -42.92
- Dividend yield
- 0.00%
- 52-week range
- $53.89 – $91.53
- Volume
- 710.97K
- Avg. volume
- 558K
Price performance
TARS price history
1M range · 20 trading sessions · Daily adjusted prices
TARS closed at $78.09 after 20 trading sessions, up 7.41% for the selected period.
- Last close
- $78.09
- Period change
- +7.41%
- Period low
- $70.65
- Period high
- $90.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $78.67 | $79.10 | $77.33 | $78.09 | 710.97K |
| Sep 17, 2026 | $78.55 | $79.78 | $77.29 | $79.03 | 474.86K |
| Sep 16, 2026 | $78.38 | $79.75 | $77.08 | $77.64 | 658.81K |
| Sep 15, 2026 | $80.01 | $80.01 | $77.77 | $78.23 | 623.99K |
| Sep 14, 2026 | $79.69 | $80.235 | $78.40 | $79.95 | 693.7K |
| Sep 11, 2026 | $82.27 | $83.225 | $79.175 | $79.31 | 490.79K |
| Sep 10, 2026 | $80.892 | $83.34 | $80.81 | $81.12 | 403.28K |
| Sep 9, 2026 | $86.31 | $87.31 | $82.67 | $82.77 | 565.45K |
| Sep 8, 2026 | $89.67 | $90.75 | $87.01 | $87.22 | 1.82M |
| Sep 4, 2026 | $82.70 | $91.53 | $81.07 | $90.78 | 1.6M |
| Sep 3, 2026 | $82.76 | $84.50 | $81.9454 | $83.205 | 733.75K |
| Sep 2, 2026 | $74.63 | $82.97 | $74.105 | $82.76 | 1.9M |
| Sep 1, 2026 | $73.86 | $75.08 | $73.515 | $74.05 | 587.27K |
| Aug 31, 2026 | $71.47 | $74.935 | $70.71 | $74.24 | 711.97K |
| Aug 28, 2026 | $71.19 | $72.03 | $70.73 | $71.76 | 615.74K |
| Aug 27, 2026 | $70.07 | $72.145 | $69.465 | $71.92 | 876.93K |
| Aug 26, 2026 | $71.10 | $71.15 | $69.77 | $70.65 | 611.55K |
| Aug 25, 2026 | $72.55 | $74.00 | $71.05 | $71.45 | 538.35K |
| Aug 24, 2026 | $72.88 | $73.08 | $71.765 | $72.81 | 414.07K |
| Aug 21, 2026 | $71.72 | $73.135 | $71.26 | $72.70 | 636.34K |
Latest TARS news
The latest Smart Investors Daily articles mentioning TARS.
Stock researchResearch & News · SEC Filings
Loading stock research…